2-190060319-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005259.3(MSTN):​c.490G>A​(p.Glu164Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00121 in 1,612,876 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 25 hom. )

Consequence

MSTN
NM_005259.3 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.22

Publications

19 publications found
Variant links:
Genes affected
MSTN (HGNC:4223): (myostatin) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein negatively regulates skeletal muscle cell proliferation and differentiation. Mutations in this gene are associated with increased skeletal muscle mass in humans and other mammals. [provided by RefSeq, Jul 2016]
C2orf88 (HGNC:28191): (chromosome 2 open reading frame 88) Predicted to enable protein kinase A regulatory subunit binding activity. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031317472).
BP6
Variant 2-190060319-C-T is Benign according to our data. Variant chr2-190060319-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 333238.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00143 (217/151986) while in subpopulation EAS AF = 0.0283 (146/5166). AF 95% confidence interval is 0.0245. There are 1 homozygotes in GnomAd4. There are 121 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 25 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MSTNNM_005259.3 linkc.490G>A p.Glu164Lys missense_variant Exon 2 of 3 ENST00000260950.5 NP_005250.1 O14793Q53S46
AKAP19XM_047446008.1 linkc.-517-19635C>T intron_variant Intron 2 of 6 XP_047301964.1
AKAP19XM_047446009.1 linkc.-517-19635C>T intron_variant Intron 1 of 5 XP_047301965.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MSTNENST00000260950.5 linkc.490G>A p.Glu164Lys missense_variant Exon 2 of 3 1 NM_005259.3 ENSP00000260950.3 O14793
C2orf88ENST00000478197.1 linkn.220-18904C>T intron_variant Intron 1 of 1 4
C2orf88ENST00000495546.1 linkn.202-19635C>T intron_variant Intron 1 of 2 4

Frequencies

GnomAD3 genomes
AF:
0.00143
AC:
217
AN:
151868
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000629
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00204
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0280
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.0000945
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000442
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00326
AC:
817
AN:
250792
AF XY:
0.00281
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.00609
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0281
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.00278
GnomAD4 exome
AF:
0.00119
AC:
1738
AN:
1460890
Hom.:
25
Cov.:
31
AF XY:
0.00113
AC XY:
823
AN XY:
726760
show subpopulations
African (AFR)
AF:
0.000419
AC:
14
AN:
33440
American (AMR)
AF:
0.00540
AC:
241
AN:
44662
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26082
East Asian (EAS)
AF:
0.0264
AC:
1048
AN:
39674
South Asian (SAS)
AF:
0.00208
AC:
179
AN:
86228
European-Finnish (FIN)
AF:
0.000150
AC:
8
AN:
53404
Middle Eastern (MID)
AF:
0.000869
AC:
5
AN:
5756
European-Non Finnish (NFE)
AF:
0.0000216
AC:
24
AN:
1111300
Other (OTH)
AF:
0.00363
AC:
219
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
106
211
317
422
528
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00143
AC:
217
AN:
151986
Hom.:
1
Cov.:
32
AF XY:
0.00163
AC XY:
121
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.000627
AC:
26
AN:
41488
American (AMR)
AF:
0.00197
AC:
30
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.0283
AC:
146
AN:
5166
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4810
European-Finnish (FIN)
AF:
0.0000945
AC:
1
AN:
10586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000442
AC:
3
AN:
67926
Other (OTH)
AF:
0.00142
AC:
3
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00115
Hom.:
6
Bravo
AF:
0.00187
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00302
AC:
367
Asia WGS
AF:
0.0150
AC:
54
AN:
3478
EpiCase
AF:
0.0000546
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 27, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Myostatin-related muscle hypertrophy Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
16
DANN
Benign
0.94
DEOGEN2
Benign
0.32
T
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.47
T
MetaRNN
Benign
0.0031
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.90
L
PhyloP100
1.2
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.075
Sift
Benign
0.47
T
Sift4G
Benign
0.41
T
Polyphen
0.0
B
Vest4
0.13
MVP
0.46
MPC
0.27
ClinPred
0.0052
T
GERP RS
1.6
Varity_R
0.11
gMVP
0.22
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35781413; hg19: chr2-190925045; API